Edmonds Duncan Registered Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,952
Closed -$227K 113
2020
Q2
$227K Sell
2,952
-300
-9% -$23K 0.1% 95
2020
Q1
$243K Buy
3,252
+22
+0.7% +$1.52K 0.12% 91
2019
Q4
$210K Sell
3,230
-100
-3% -$6.51K 0.09% 103
2019
Q3
$211K Sell
3,330
-400
-11% -$26.1K 0.09% 101
2019
Q2
$253K Hold
3,730
0.1% 101
2019
Q1
$242K Sell
3,730
-200
-5% -$13.3K 0.1% 105
2018
Q4
$246K Sell
3,930
-1,900
-33% -$133K 0.12% 101
2018
Q3
$450K Sell
5,830
-540
-8% -$40.8K 0.18% 75
2018
Q2
$451K Buy
6,370
+100
+2% +$7.06K 0.2% 72
2018
Q1
$473K Buy
6,270
+284
+5% +$22.6K 0.21% 68
2017
Q4
$428K Buy
5,986
+100
+2% +$7.59K 0.19% 73
2017
Q3
$430K Sell
5,886
-500
-8% -$38.2K 0.2% 71
2017
Q2
$452K Buy
6,386
+100
+2% +$6.65K 0.26% 65
2017
Q1
$429K Buy
6,286
+200
+3% +$14.1K 0.23% 66
2016
Q4
$436K Buy
6,086
+50
+0.8% +$3.72K 0.25% 62
2016
Q3
$438K Buy
6,036
+100
+2% +$8.12K 0.27% 68
2016
Q2
$478K Buy
5,936
+701
+13% +$62.2K 0.29% 62
2016
Q1
$481K Sell
5,235
-185
-3% -$16.7K 0.32% 57
2015
Q4
$548K Buy
+5,420
New +$564K 0.38% 52

Other funds holding GILD

Edmonds Duncan Registered Investment Advisors's GILD Position: Q3 2020 in Review

Edmonds Duncan Registered Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,952 shares — an estimated $227K sold.

Edmonds Duncan Registered Investment Advisors first reported a position in GILD in Q4 2015 and held it in 19 quarters. The position peaked at $548K in Q4 2015. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Edmonds Duncan Registered Investment Advisors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Edmonds Duncan Registered Investment Advisors sold 2,952 Gilead Sciences shares in Q3 2020, an estimated $227K.
  • Edmonds Duncan Registered Investment Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 19 quarters.
  • Edmonds Duncan Registered Investment Advisors's Gilead Sciences position peaked at $548K in Q4 2015.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Edmonds Duncan Registered Investment Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.